Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D

Journal of Experimental Medicine

Volumn 204, Issue 6, 2007, Pages 1311-1317

  Campbell, Jessica A ^a   Trossman, David S ^a   Yokoyama, Wayne M ^a   Carayannopoulos, Leonidas N ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; COMPETITIVE INHIBITION; COWPOX; HOST CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; LIGAND BINDING; MONKEYPOX; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOPOXVIRUS; PRIORITY JOURNAL; PROTEIN SECRETION; RECEPTOR BLOCKING; RODENT;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CONSERVED SEQUENCE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; MARKOV CHAINS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; ORTHOPOXVIRUS; RECEPTORS, IMMUNOLOGIC; SEQUENCE ANALYSIS, DNA;

EID: 34250349552     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20062026     Document Type: Article

References (30)

1. Ogasawara, K., and L.L. Lanier. 2005. NKG2D in NK and T cell-mediated immunity. J. Clin. Immunol. 25:534-540.
2. Krmpotic, A., D.H. Busch, I. Bubic, F. Gebhardt, H. Hengel, M. Hasan, A.A. Scalzo, U.H. Koszinowski, and S. Jonjic. 2002. MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat. Immunol. 3:529-535.
3. Welte, S.A., C. Sinzger, S.Z. Lutz, H. Singh-Jasuja, K.L. Sampaio, U. Eknigk, H.G. Rammensee, and A. Steinle. 2003. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur. J. Immunol. 33:194-203.
4. Dunn, C., N.J. Chalupny, C.L. Sutherland, S. Dosch, P.V. Sivakumar, D.C. Johnson, and D. Cosman. 2003. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J. Exp. Med. 197:1427-1439.
5. Lodoen, M.B., G. Abenes, S. Umamoto, J.P. Houchins, F. Liu, and L.L. Lanier. 2004. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. J. Exp. Med. 200:1075-1081.
6. Krmpotic, A., M. Hasan, A. Loewendorf, T. Saulig, A. Halenius, T. Lenac, B. Polic, I. Bubic, A. Kriegeskorte, E. Pernjak-Pugel, et al. 2005. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J. Exp. Med. 201:211-220.
7. Lenac, T., M. Budt, J. Arapovic, M. Hasan, A. Zimmermann, H. Simic, A. Krmpotic, M. Messerle, Z. Ruzsics, U.H. Koszinowski, et al. 2006. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J. Exp. Med. 203:1843-1850.
8. Strong, R.K., and B.J. McFarland. 2004. NKG2D and Related Immunoreceptors. Adv. Protein Chem. 68:281-312.
9. Arase, H., E.S. Mocarski, A.E. Campbell, A.B. Hill, and L.L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 296:1323-1326.
10. Smith, H.R., J.W. Heusel, I.K. Mehta, S. Kim, B.G. Dorner, O.V. Naidenko, K. Iizuka, H. Furukawa, D.L. Beckman, J.T. Pingel, et al. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA. 99:8826-8831.
11. Seet, B.T., J.B. Johnston, C.R. Brunetti, J.W. Barrett, H. Everett, C. Cameron, J. Sypula, S.H. Nazarian, A. Lucas, and G. McFadden. 2003. Poxviruses and immune evasion. Annu. Rev. Immunol. 21:377-423.
12. Hughey, R., and A. Krogh. 1996. Hidden Markov models for sequence analysis: extension and analysis of the basic method. Comput. Appl. Biosci. 12:95-107.
13. Karplus, K., C. Barrett, and R. Hughey. 1998. Hidden Markov models for detecting remote protein homologies. Bioinformatics. 14:846-856.
14. Likos, A.M., S.A. Sammons, V.A. Olson, A.M. Frace, Y. Li, M. Olsen-Rasmussen, W. Davidson, R. Galloway, M.L. Khristova, M.G. Reynolds, et al. 2005. A tale of two clades: monkeypox viruses. J. Gen. Virol. 86:2661-2672.
15. Chen, N., G. Li, M.K. Liszewski, J.P. Atkinson, P.B. Jahrling, Z. Feng, J. Schriewer, C. Buck, C. Wang, E.J. Lefkowitz, et al. 2005. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology. 340:46-63.
16. Gubser, C., S. Hue, P. Kellam, and G.L. Smith. 2004. Poxvirus genomes: a phylogenetic analysis. J. Gen. Virol. 85:105-117.
17. Shi, J., T.L. Blundell, and K. Mizuguchi. 2001. FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. J. Mol. Biol. 310:243-257.
18. O'Callaghan, C.A., A. Cerwenka, B.E. Willcox, L.L. Lanier, and P.J. Bjorkman. 2001. Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60. Immunity. 15:201-211.
19. Carayannopoulos, L.N., O.V. Naidenko, J. Kinder, E.L. Ho, D.H. Fremont, and W.M. Yokoyama. 2002. Ligands for murine NKG2D display heterogeneous binding behavior. Eur. J. Immunol. 32:597-605.
20. Diefenbach, A., A.M. Jamieson, S.D. Liu, N. Shastri, and D.H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:119-126.
21. Khodakevich, L., M. Szczeniowski, D. Manbu-ma-Disu, Z. Jezek, S. Marennikova, J. Nakano, and D. Messinger. 1987. The role of squirrels in sustaining monkeypox virus transmission. Trop. Geogr. Med. 39:115-122.
22. Chantrey, J., H. Meyer, D. Baxby, M. Begon, K.J. Bown, S.M. Hazel, T. Jones, W.I. Montgomery, and M. Bennett. 1999. Cowpox: reservoir hosts and geographic range. Epidemiol. Infect. 122:455-460.
23. Carayannopoulos, L.N., O.V. Naidenko, D.H. Fremont, and W.M. Yokoyama. 2002. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J. Immunol. 169:4079-4083.
24. Karre, K., H.G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature. 319:675-678.
25. Filion, R.J., and A.S. Popel. 2005. Intracoronary administration of FGF-2: a computational model of myocardial deposition and retention. Am. J. Physiol. Heart Circ. Physiol. 288:H263-H279.
26. Francis, K., and B.O. Palsson. 1997. Effective intercellular communication distances are determined by the relative time constants for cyto/chemokine secretion and diffusion. Proc. Natl. Acad. Sci. USA. 94:12258-12262.
27. Groh, V., J. Wu, C. Yee, and T. Spies. 2002. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature. 419:734-738.
28. Samuel, D., T.K. Kumar, G. Ganesh, G. Jayaraman, P.W. Yang, M.M. Chang, V.D. Trivedi, S.L. Wang, K.C. Hwang, D.K. Chang, and C. Yu. 2000. Proline inhibits aggregation during protein refolding. Protein Sci. 9:344-352.
29. Ho, E.L., L.N. Carayannopoulos, J. Poursine-Laurent, J. Kinder, B. Plougastel, H.R. Smith, and W.M. Yokoyama. 2002. Costimulation of multiple NK cell activation receptors by NKG2D. J. Immunol. 169:3667-3675.
30. Nybakken, G.E., T. Oliphant, S. Johnson, S. Burke, M.S. Diamond, and D.H. Fremont. 2005. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature. 437:764-769.